Investments

Uranium
Oil & Gas
Precious Metals
Base Metals
Potash, Lithium and Rare Earths
Energy Related Technology
Technology & Biotechnology
Other Technology
Enter information to receive updates

Technology & Biotechnology


Not all investees are displayed – click on Disclosure Criteria link for explanation

Click here to read Pinetree’s Disclosure Criteria

Since its inception, Pinetree has invested in technology and biotechnology companies. Our successful track record of investing in these areas gave us the financial footing to pursue resource investment opportunities in early 2002. While our current focus is on the resource sector, we continue to hold investments in the technology and biotechnology sectors. We are always looking for new compelling opportunities and occasionally invest in new technology and biotechnology companies which we believe will create a strong return for our shareholders.

Investments as at September 30, 2009


Kyoto Planet Capital Partners (private)
Technology and other
15,000,000 common shares

View22 Technology Inc. (private)
Technology and Other
1,138,000 common shares
$525,000 convertible debenture
150,000 warrants expire Jul 8, 2010
500,000 warrants expire Aug 2, 2010

Antisense Therapeutics Limited (ANP:ASX)
Biotechnology Investments
37,500,000 common shares
Biotechnology
2,459,500 common shares
©Copyright 2010 Pinetree Capital Ltd.